Tukysa, combined with Herceptin and Perjeta, extends progression-free survival in HER2+ metastatic breast cancer, showing ...

Ichor Holdings (ICHR) is rated BUY, with fundamentals expected to improve in 2026 and a bottoming share price creating an attractive entry point. ICHR's new CEO is focused on operational discipline ...

The latest announcement is out from Trinity Biotech ( (TRIB) ).

Menu Price Action -- Good Times core menu prices have increased about 1% since January 2024, with minimal premium to competitors; Bad Daddy’s anticipates less than 1% blended year-over-year pricing ...

Total Annual Recurring Revenue (ARR) -- $223.6 million, up 9% year over year, contributing to 83% recurring revenue versus 79% in Q3 last year. Subscription Revenue -- 47% of total revenue in the ...

Today's global workers and their employers are at risk of triggering US tax and compliance obligations. The stakes are high for CPAs serving global ...

Celebrating the anniversary of the world's first kidney transplant, the Renown Transplant Institute team announces they have completed their second and third living donor kidney transplants, building ...

The race to be the world’s fastest road car has shifted from wild claims to carefully modeled science, and few machines ...

You know the basics: Drop 20 per cent on an investment, and you need a 25 per cent gain to break even. Lose 33 per cent, and ...

Significant progress is being reported by Standard Lithium, as the company announces it has received non-binding letters of interest for financing exceeding ...

Discover why SQM shares are outperforming, with robust EBITDA margins and expected EPS growth in 2026. Click here to read my ...